Table 4.
Model | Leuk1 | Lung1 | Leuk2 | SRBCT | Breast | Lung2 | DLBCL | Leuk3 | Cancers | GCM | Aver ± std |
---|---|---|---|---|---|---|---|---|---|---|---|
HC-TSP∗ | 97.06 | 71.88 | 80 | 95 | 66.67 | 83.58 | 83.33 | 77.68 | 74.32 | 52.17 | 78.17 ± 13.17 |
(4) | (4) | (4) | (6) | (8) | (8) | (10) | (12) | (20) | (26) | (10.2) | |
| |||||||||||
HC-K-TSP∗ | 97.06 | 78.13 | 100 | 100 | 66.67 | 94.03 | 83.33 | 82.14 | 82.43 | 67.39 | 85.12 ± 12.42 |
(36) | (20) | (24) | (30) | (24) | (28) | (46) | (64) | (128) | (134) | (53.4) | |
| |||||||||||
DT∗ | 85.29 | 78.13 | 80 | 75 | 73.33 | 88.06 | 86.67 | 75.89 | 68.92 | 52.17 | 76.35 ± 10.49 |
(2) | (4) | (2) | (3) | (4) | (5) | (5) | (16) | (10) | (18) | (6.9) | |
| |||||||||||
PAM∗ | 97.06 | 78.13 | 93.33 | 95 | 93.33 | 100 | 90 | 93.75 | 87.84 | 56.52 | 88.5 ± 12.71 |
(44) | (13) | (62) | (285) | (4,822) | (614) | (3,949) | (3,338) | (2,008) | (1,253) | (1,638.8) | |
| |||||||||||
mRMR-SVM | 76.47 | 78.13 | 100.00 | 75.00 | 96.67 | 95.52 | 96.67 | 91.96 | 71.62 | 45.65 | 82.77 ± 16.85 |
(7) | (13) | (19) | (9) | (97) | (120) | (16) | (119) | (89) | (57) | (54.6) | |
| |||||||||||
SVM-RFE-SVM | 85.29 | 78.13 | 93.33 | 95.00 | 90.00 | 88.06 | 90.00 | 91.07 | 93.24 | 63.04 | 86.72 ± 9.62 |
(5) | (9) | (8) | (3) | (7) | (9) | (13) | (35) | (29) | (199) | (31.7) | |
| |||||||||||
TSG | 97.06 | 81.25 | 100 | 100 | 86.67 | 95.52 | 93.33 | 91.07 | 79.73 | 67.39 | 89.20 ± 10.5 |
(6) | (20) | (44) | (13) | (63) | (60) | (16) | (95) | (81) | (112) | (51) | |
| |||||||||||
χ 2-IRG-DC | 97.06 | 84.38 | 100 | 100 | 90 | 97.01 | 93.33 | 93.75 | 85.14 | 67.39 | 90.81 ± 9.91 |
(29) | (23) | (20) | (23) | (31) | (52) | (37) | (46) | (47) | (64) | (37.2) |
*Results reported in [28].